Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151539 · ClinicalTrials.gov registry record
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- 19
- Enrollment target
NCT02151539 is a clinical trial that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 19 participants.
The verdict
NCT02151539 was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This research trial studies medical chart review in determining outcomes of second-line therapy in patients with acute graft-versus-host disease previously treated with extracorporeal photopheresis or other systemic therapies. Gathering information about second-line therapy in patients with acute graft-versus-host disease may help doctors learn more about the disease and find better treatment.
Interventions
- OTHER medical chart review
- OTHER quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-08-29 |
| Est. Completion | 2018-10-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151539
The ClinicalTrials.gov registry entry for NCT02151539 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which medical chart review is the first listed.
NCT02151539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02151539 about?
NCT02151539 is a clinical study titled "Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)". This research trial studies medical chart review in determining outcomes of second-line therapy in patients with acute graft-versus-host disease previously treated with extracorporeal photopheresis or other systemic therapies. Gathering information about second-line therapy in patients with acute gr...
What is the current status of trial NCT02151539?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2014-08-29. Estimated completion is 2018-10-11.
What interventions are being tested in trial NCT02151539?
The interventions under investigation include: medical chart review (OTHER), quality-of-life assessment (OTHER).
Who is sponsoring clinical trial NCT02151539?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.